CN109865078A - A kind of formula for treating hepatitis A - Google Patents
A kind of formula for treating hepatitis A Download PDFInfo
- Publication number
- CN109865078A CN109865078A CN201711270664.XA CN201711270664A CN109865078A CN 109865078 A CN109865078 A CN 109865078A CN 201711270664 A CN201711270664 A CN 201711270664A CN 109865078 A CN109865078 A CN 109865078A
- Authority
- CN
- China
- Prior art keywords
- formula
- hepatitis
- radix
- campanulaceae
- pheretima
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention is a kind of formula for treating hepatitis A, raw material in formula forms by weight percentage: Schisandra chinensis 5-15%, semen plantaginis 1-5%, Poria cocos 1-10%, fructus lycii 5-15%, raw rhubarb 3-9%, longevity greens/mustard green 2-3%, cape jasmine 1-5%, white peony 11-19%, caulis lonicerae 5-7%, polygonum cuspidate 3-5%, herba lysimachiae 3-5%, set hay melon 1-5%, iron holly bark 5-10%, campanulaceae 1-1.5%, Radix Salviae Miltiorrhizae 4-5%, calyx meto 2-4%, pheretima 0.4-0.6%, radix tylophorae 1-2%, corn stigma 2-4%, paris polyphylla 1-3%, treatment hepatitis A of the invention, which has to stablize to be depressured, not to rebound, blood pressure effect steady in a long-term, it is not required to Long-term taking medicine, there is no drug resistance, safety is without side-effects, it is suitble to the crowd taken extensive , it is the intimate medicine of common people.
Description
Technical field
The present invention is a kind of formula for treating hepatitis A, belongs to pharmaceutical field.
Background technique
When flu, body temperature is often up to 38.5 ° or more, generally has sweating heat not move back or the hot person's two states of lossless body, most
Patient can be using taking treatment hepatitis A or hanging water, and treatment hepatitis A is that one kind can make human body peripheral vascular by adjusting function of human body
Expansion and then increase heat dissipation by means of the processes such as perspire, while the drug for the body heat production reduction that inhibits to shiver with cold, make, but treats
Hepatitis A is mostly with toxic side effect, such as the reaction of drug rash, gastrointestinal reaction, hematological system and the damage to hepatic and renal function, especially
When using long or such drug being excessively used, toxic side effect is more significant, and Chinese medicine thinks cat fever, is because the five internal organs improve five gas
Physical efficiency and raw body temperature are generated, if the five internal organs improve five gas, heat cannot be arranged, and be skin pore by wind, heat, cold, wet, dryness-heat gas-tight
Plug, i.e. lung gold pore convergence (lung governing skin and hair) cause body temperature, hot gas that can not be discharged from skin pore, currently, the prescription that Chinese medicine is brought down a fever
Very much, quality is irregular, and curative effect differs greatly.
Summary of the invention
In view of the above existing problems in the prior art, the present invention provides a kind of formulas for treating hepatitis A, can increase heat resistanceheat resistant
Shake stability and high-temperature behavior and low in cost.
To achieve the goals above, the invention is realized by the following technical scheme: a kind of to treat hepatitis A, the raw material in formula
Forming by weight percentage is respectively: Schisandra chinensis 5-15%, semen plantaginis 1-5%, Poria cocos 1-10%, fructus lycii 5-15%, raw rhubarb
3-9%, longevity greens/mustard green 2-3%, cape jasmine 1-5%, white peony 11-19%, caulis lonicerae 5-7%, polygonum cuspidate 3-5%, herba lysimachiae 3-5%,
Set hay melon 1-5%, iron holly bark 5-10%, campanulaceae 1-1.5%, Radix Salviae Miltiorrhizae 4-5%, calyx meto 2-4%, pheretima 0.4-0.6%, baby
Rattan 1-2%, corn stigma 2-4%, paris polyphylla 1-3%.
The utility model has the advantages that preparing treatment hepatitis A by this method is pure Chinese medicine formula, compatibility is scientific, and the medicine is rapid-action, treats
It imitates, safety is without side-effects.
Specific embodiment
Embodiment 1
A kind of formula for treating hepatitis A, the raw material in formula forms by weight percentage is respectively: Schisandra chinensis 5%, Chinese herbaceous peony
Sub 1%, Poria cocos 1%, fructus lycii 5%, raw rhubarb 3%, longevity greens/mustard green 2%, cape jasmine 1%, white peony 11%, caulis lonicerae 5%, polygonum cuspidate
3%, herba lysimachiae 3%, tree hay melon 1%, iron holly bark 5%, campanulaceae 1%, Radix Salviae Miltiorrhizae 4%, calyx meto 2%, pheretima 0.4%, radix tylophorae
1%, corn stigma 2%, paris polyphylla 1%, the heat-resistant knocking stability for treating hepatitis A at this time is excellent, but high temperature resistant property is insufficient.
Embodiment 2
A kind of formula for treating hepatitis A, the raw material in formula forms by weight percentage is respectively: Schisandra chinensis 15%, Chinese herbaceous peony
Sub 5%, Poria cocos 10%, fructus lycii 15%, raw rhubarb 9%, longevity greens/mustard green 3%, cape jasmine 5%, white peony 19%, caulis lonicerae 7%, polygonum cuspidate
5%, herba lysimachiae 5%, tree hay melon 5%, iron holly bark 10%, campanulaceae 1.5%, Radix Salviae Miltiorrhizae 5%, calyx meto 4%, pheretima 0.6%, baby
Rattan 2%, corn stigma 4%, paris polyphylla 3%, treat hepatitis A high temperature resistant property with higher at this time but its anti-thermal shock is steady
Qualitative deficiency.
Embodiment 3
A kind of formula for treating hepatitis A, the raw material in formula forms by weight percentage is respectively: Schisandra chinensis 10%, Chinese herbaceous peony
Sub 3%, Poria cocos 7%, fructus lycii 10%, raw rhubarb 6%, longevity greens/mustard green 2.3%, cape jasmine 1.5%, white peony 15%, caulis lonicerae
5.7%, polygonum cuspidate 3.5%, herba lysimachiae 3.5%, tree hay melon 1.5%, iron holly bark 8%, campanulaceae 1.35%, Radix Salviae Miltiorrhizae 4.5%, calyx meto
2.4%, pheretima 0.5%, radix tylophorae 1.2%, corn stigma 2.4%, paris polyphylla 1.3% treat hepatitis A with higher at this time
Health thermal shock resistance and high temperature resistant property.
Claims (4)
1. a kind of formula for treating hepatitis A, which is characterized in that the raw material in formula forms by weight percentage is respectively: Schisandra chinensis
It is 5-15%, semen plantaginis 1-5%, Poria cocos 1-10%, fructus lycii 5-15%, raw rhubarb 3-9%, longevity greens/mustard green 2-3%, cape jasmine 1-5%, white
Chinese herbaceous peony 11-19%, caulis lonicerae 5-7%, polygonum cuspidate 3-5%, herba lysimachiae 3-5%, tree hay melon 1-5%, iron holly bark 5-10%, campanulaceae 1-
1.5%, Radix Salviae Miltiorrhizae 4-5%, calyx meto 2-4%, pheretima 0.4-0.6%, radix tylophorae 1-2%, corn stigma 2-4%, paris polyphylla
1-3%.
2. the formula for the treatment of hepatitis A according to claim 1, which is characterized in that the raw material group by weight percentage in formula
At being respectively: Schisandra chinensis 5%, semen plantaginis 1%, Poria cocos 1%, fructus lycii 5%, raw rhubarb 3%, longevity greens/mustard green 2%, cape jasmine 1%, Radix Paeoniae Alba
Medicine 11%, caulis lonicerae 5%, polygonum cuspidate 3%, herba lysimachiae 3%, tree hay melon 1%, iron holly bark 5%, campanulaceae 1%, Radix Salviae Miltiorrhizae 4%, calyx meto
2%, pheretima 0.4%, radix tylophorae 1%, corn stigma 2%, paris polyphylla 1%.
3. the formula for the treatment of hepatitis A according to claim 1, which is characterized in that the raw material group by weight percentage in formula
At being respectively: Schisandra chinensis 15%, semen plantaginis 5%, Poria cocos 10%, fructus lycii 15%, raw rhubarb 9%, longevity greens/mustard green 3%, cape jasmine 5%,
White peony 19%, caulis lonicerae 7%, polygonum cuspidate 5%, herba lysimachiae 5%, tree hay melon 5%, iron holly bark 10%, campanulaceae 1.5%, Radix Salviae Miltiorrhizae
5%, calyx meto 4%, pheretima 0.6%, radix tylophorae 2%, corn stigma 4%, paris polyphylla 3%.
4. the formula for the treatment of hepatitis A according to claim 1, which is characterized in that the raw material group by weight percentage in formula
At being respectively: Schisandra chinensis 10%, semen plantaginis 3%, Poria cocos 7%, fructus lycii 10%, raw rhubarb 6%, longevity greens/mustard green 2.3%, cape jasmine
1.5%, white peony 15%, caulis lonicerae 5.7%, polygonum cuspidate 3.5%, herba lysimachiae 3.5%, tree hay melon 1.5%, iron holly bark 8%, campanulaceae
1.35%, Radix Salviae Miltiorrhizae 4.5%, calyx meto 2.4%, pheretima 0.5%, radix tylophorae 1.2%, corn stigma 2.4%, paris polyphylla
1.3%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711270664.XA CN109865078A (en) | 2017-12-05 | 2017-12-05 | A kind of formula for treating hepatitis A |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711270664.XA CN109865078A (en) | 2017-12-05 | 2017-12-05 | A kind of formula for treating hepatitis A |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109865078A true CN109865078A (en) | 2019-06-11 |
Family
ID=66916689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711270664.XA Pending CN109865078A (en) | 2017-12-05 | 2017-12-05 | A kind of formula for treating hepatitis A |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109865078A (en) |
-
2017
- 2017-12-05 CN CN201711270664.XA patent/CN109865078A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104095786A (en) | Traditional Chinese medicine shampoo capable of relieving itch and removing dandruffs | |
CN103285221B (en) | A kind of Chinese medicine of heat-clearing and toxic substances removing | |
CN109833425A (en) | A kind of formula of hypoglycemic agent | |
CN109865078A (en) | A kind of formula for treating hepatitis A | |
CN104189784A (en) | Traditional Chinese medicine preparation for aphtha and preparation method of traditional Chinese medicine preparation | |
CN107789572A (en) | A kind of formula of slimming drugs | |
CN109833440A (en) | A kind of formula for treating hepatitis | |
CN109833453A (en) | A kind of formula of depressor | |
CN109865094A (en) | A kind of formula for treating hepatitis B | |
CN109865102A (en) | A kind of formula for treating depression | |
CN107737266A (en) | A kind of formula for treating hepatitis A | |
CN109833451A (en) | A kind of formula of slimming drugs | |
CN109865054A (en) | It is a kind of to treat cardiopathic formula | |
CN109833401A (en) | A kind of formula of antalgica | |
CN109865074A (en) | A kind of formula for treating headache | |
CN109833444A (en) | A kind of formula of health care medicinal | |
CN109876110A (en) | A kind of formula for treating stomach trouble | |
CN109833459A (en) | A kind of formula of cough medicine | |
CN109833448A (en) | A kind of formula of hypolipidemic | |
CN109833449A (en) | A kind of formula for treating AIDS | |
CN107737278A (en) | A kind of formula of health care medicinal | |
CN107693753A (en) | A kind of formula of depressor | |
CN107823385A (en) | A kind of formula of antalgica | |
CN109833435A (en) | A kind of formula of medicament for treating scald | |
CN102908532A (en) | Traditional Chinese medicine for treating thromboangiitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190611 |